Alkermes plc NMS · ALKS

Alcohol Use Disorder Market Set to Expand at a 12.1% CAGR During the Forecast Period (2026–2036), Owing to the Emergence of Novel Mechanisms Such as 5-HT3 Pathway, NOP Receptor, mGluR5 NAM, and Other | DelveInsight

GlobeNewswire Inc. · 42d ago

Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake

The Motley Fool · 147d ago

Spyre Therapeutics Stock Surges This Past Year as $10.5 Million Buy Lifts Stake to $78 Million

The Motley Fool · 147d ago

Avadel Pharmaceuticals Announces Outcome of the Court Sanction Hearing

Benzinga · 160d ago

Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes

Benzinga · 189d ago

Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting

Benzinga · 229d ago

Deal Dispatch: From Four Roses Bourbon To Quantum Stakes, Here Are This Week's Sector Shake Ups

Benzinga · 269d ago

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avadel Pharmaceuticals plc (NASDAQ: AVDL)

Benzinga · 271d ago

Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz

Benzinga · 271d ago

6 Analysts Assess Alkermes: What You Need To Know - Benzinga

Benzinga · 735d ago

Orchestra BioMed Holdings, Inc. (OBIO) Stock Jumps 7.3%: Will It Continue to Soar?

Zacks Investment Research · 757d ago

Why Is Alkermes (ALKS) Down 2.7% Since Last Earnings Report?

Zacks Investment Research · 780d ago

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Zacks Investment Research · 785d ago

Do Options Traders Know Something About Alkermes (ALKS) Stock We Don't?

Zacks Investment Research · 791d ago

Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates

Zacks Investment Research · 809d ago

Alkermes (ALKS) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks Investment Research · 811d ago

Deciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks Investment Research · 817d ago

Will Alkermes' (ALKS) Proprietary Drugs Aid Amid Competition?

Zacks Investment Research · 819d ago

Alkermes (ALKS) Earnings Expected to Grow: What to Know Ahead of Q1 Release

Zacks Investment Research · 824d ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks Investment Research · 826d ago

Alkermes' (ALKS) ALKS 2680 Betters Wakefulness in Phase Ib Study

Zacks Investment Research · 830d ago

Why Alkermes (ALKS) is a Top Growth Stock for the Long-Term

Zacks Investment Research · 832d ago

Alkermes' Sleeping Disorder Studies' Data Look Excellent, Analyst Says

Benzinga · 832d ago

Breaking Down Alkermes: 5 Analysts Share Their Views

Benzinga · 832d ago

Why Alkermes (ALKS) is Poised to Beat Earnings Estimates Again

Zacks Investment Research · 839d ago